click to go to the homepage
Menopause Pharmacokinetics Mechanism of Action Clin. Experience Tolerability Health Economics Resources
Livial has a low incidence of breast tenderness and does not increase mammographic density.  
Members log-in ORGYN online magazine Spotlights
     
  Username:
  
About VIP Pass
Forgot password?
  Password:
  
 
 
Edit your VIP pass

Register here

  First time visitor? VIP pass allows access to this website and all other sites that display the VIP Pass logo. Benefits of VIP
Registration is free and easy:

Livial® (tibolone) is a first choice treatment for the relief of climacteric symptoms and prevention of osteoporosis in postmenopausal women as it regulates the estrogenic activity in a tissue-selective way. This results in desired estrogenic effects in tissues like the brain, bone and vagina, while avoiding the undesired estrogenic effects on the endometrium and the breast.
Best of the ORGYN Reviews
Highlights of the past year’s articles. Read more
Hormone therapy update
Current thinking is summarized in a new review paper. Read more
Sexual Well Being after 50
EMAS symposium Istanbul
Tibolone: new results from key clinical trials
WCGE symposium Florence
Expert Meeting
7 Experts about managing Menopause
European menopause survey
European women's attitude towards menopause and menopausal treatments
Women's Health Update
Free weekly newsletter
click to go to http://www.schering-plough.com About this site | Prescribing information | Other countries
Terms of use | Privacy statement | About us
© 2008 Schering–Plough Corporation